Minimal inhibitory concentrations of rifampin for different species of mycobacteria were determined in 7H-10 agar medium and Lowenstein-Jensen egg medium. When rifampin was incorporated into egg medium, approximately 90% of its activity was lost. A 10-mg amount of rifampin (Pitman-Moore, Division of Dow Chemical Co., Indianapolis, Ind.) was solubilized in 2 ml of absolute ethyl alcohol, and 8 ml of distilled water was added to obtain a working stock solution of 1,000 gg/ml. Aqueous dilutions ofrifampin could be made from this stock solution.
The present study was undertaken to determine (i) the stability of aqueous solutions of rifampin on storage at different temperatures, (ii) the minimal inhibitory concentration (MIC) of rifampin for mycobacteria grown on Middlebrook 7H-10 agar medium, (iii) the antituberculous activity of rifampin in comparison to INH, and (iv) the antimicrobial effect of rifampin-INH combinations on M. intracellulare in 7H-10 medium and under simulated in vivo conditions of the Laboratory Model Man (7) .
MATERIALS AND METHODS
The 62 strains of mycobacteria employed in this study included 21 strains of M. tuberculosis, 16 strains of M. intracellulare, and 5 strains each of M. kansasii, M. terrae complex, M. fortuitum, tap water scotochromogens, and scrofula scotochromogens. The drug susceptibility patterns of all strains were established for INH, dihydrostreptomycin sulfate, para-aminosalicylic acid (PAS), ethionamide, ethambutol, viomycin, kanamycin, cycloserine, and pyrazinamide by the proportion method of Canetti and coworkers (1) . All mycobacterial strains other than tubercle bacilli and six strains of M. tuberculosis showed multiple drug resistance to three or more of the above mentioned drugs. The laboratory strain H37Rv and 14 other strains of M. tuberculosis were fully sensitive to all antituberculous drugs.
A 10-mg amount of rifampin (Pitman-Moore, Division of Dow Chemical Co., Indianapolis, Ind.) was solubilized in 2 ml of absolute ethyl alcohol, and 8 ml of distilled water was added to obtain a working stock solution of 1,000 gg/ml. Aqueous dilutions ofrifampin could be made from this stock solution.
To test the stability of rifampin during storage, solutions of 10, 100, and 1,000 jpg/ml of the drug were placed at -20, 4, and 25 C. After 4, 8, and 12 weeks of storage, the activity of the drug was determined by the Food and Drug Administration cylinder method (5) and a rifampin sensitive strain of Staphylococcus aureus. The MIC of rifampin for M. tuberculosis was dedetermined in both 7H-10 agar medium and Lowenstein-Jensen (LJ) egg medium. The MIC of rifampin for mycobacteria other than M. tuberculosis was determined in 7H-10 medium only. Twelve different concentrations of rifampin ranging from 0.05 to 7.5 ,ug/ml were incorporated into either 7H-10 agar medium or LJ medium. In the case of 7H-10 medium, the various drug-containing media and drug-free controls were dispensed in 5-ml amounts into quadrants of sectioned plastic petri plates; comparable batches of LI medium were dispensed in 5-ml amounts (9) . Drug discs were placed in the center of empty quadrants of plastic petri dishes, and 5 ml of 7H-10 agar was layered over each drug-containing disc. Both batches of plates were kept for 24 hr at room temperature and 48 hr at 4 C prior to their inoculation with two strains each of M. kansasii, M. intracellulare, both scrofula and tap water scotochromogens, and M. terrae. Three different sizes of bacterial inocula were tested for each strain.
In (1) .
The antimicrobial effect of INH-rifampin combinations under simulated in vivo conditions was studied in Laboratory Model Man experiments (7). One ml of 5-day-old 7H-9 broth cultures of two strains of M. intracellulare was aseptically added to a series of dialysis sacs having a pore size of 4.8 nm. The sac containing broth cultures were then exposed to different drug combinations and concentrations for 10 hr a day for 10 days.
For 10 days, each culture bag was alternately placed for 10 hr into 200 ml of 7H-9 broth containing INHrifampin and for 14 hr into 200 ml of drug-free broth. The dialysis of the drugs into and out of the culturecontaining bag into the surrounding reservoir simulated the absorption and excretion of INH and rifampin in man. The full drug concentration, i.e. the peak level, was achieved in the culture bag 4 hr after placing it in drug-containing broth. The level was maintained for 6 hr, then the culture was transferred to drug-free medium, and within 4 hr all detectable drug had disappeared. The effect of the drug combinations was expressed quantitatively by determining the numbers of surviving organisms. Beginning on the first day of the experiment, and then every other day for a 10-day period, samples were taken from each culture bag for a plate count on 7H-10 agar medium.
Organisms which survived 10 days of antimicrobial treatment with a given drug combination were tested on 7H-10 agar containing the same drugs as the treatment regimen. All cultures on 7H-10 agar medium were incubated at 37 C in an atmosphere of 10% C02, whereas other experimental cultures were incubated in regular incubators at 37 C. ,gg/ml drug concentrations, 6 to 15% were lost after only 4 weeks at temperatures from -20 C to 25 C, 7 to 31% were lost after 8 weeks, and 20 to 48% were lost after 12 weeks. The MIC range of rifampin for M. tuberculosis is shown in Fig. 1 . Each of the 15 strains tested is represented by a dot on the scattergraph; the location of each dot is dependent upon the inhibitory concentra- The MIC of rifampin in 7H-10 medium for mycobacteria other than M. tuberculosis ranges from 0.1 to more than 5.0 Mug/ml (Fig. 2) . Strains of M. kansasii were sensitive to 0.2 to 0.5 Mug/ml; scrofula scotochromogens (indicated as "scrof") were sensitive to 0.1 to 2.0 Mg/ml; M. terrae strains were sensitive to 0.15 to 2.0 ,ug/ml; tap water scotochromogens ("aquae") were sensitive to 0.5 to 5.0 ug/nml; and five strains of M. fortuitum were inhibited by rifampin concentrations ranging from 2.0 to more than 5.0 jg/ml. Sixteen strains of M. intracellulare were resistant to 1 ,ug of rifampin per ml, whereas 5 of these 16 strains were inhibited by 5 ,g/ml (Table 2) .
Comparative susceptibility tests in 7H-10 medium with either rifampin contained in discs or incorporated into the agar revealed disagreement in only 1 out of 10 strains tested. A scotochromogenic strain did not grow on medium in which 1 Mug of rifampin was incorporated per ml; however, 100 colonies grew on medium containing the appropriate rifampin drug disc.
The antituberculous activity of INH and rifampin are compared in another scattergraph (Fig.  3) . S. The antimycobacterial activity of INH-rifampin combinations against 16 strains of M. intracellulare that were resistant to 1 Mg of rifampin per ml was studied ( Table 2 ). The addition of 1 Mug of INH per ml to a rifampin concentration of (Table 2) . DISCUSSION The stability of rifampin in aqueous solutions is similar to that of aqueous solutions of dihydrostreptomycin sulfate. Both drugs lose less than 10% of their antituberculous potency if stored at 100 to 1,000 ;&g/ml concentrations at -20 C for up to 3 months. However, streptomycin remains stabile in aqueous solutions (pH 3 to 7) up to 3 months at 25 C (5), whereas solutions of 10 to 1,000 Mug of rifampin per ml lost 25 to 48% of their activity under these conditions. When rifampin was incorporated into an inspissated egg medium such as Lowenstein-Jensen, there was approximately a 90% loss of activity. Only 11 to 20% of rifampin activity was lost by boiling or autoclaving in aqueous solutions. Therefore, rifampin, like streptomycin, seems to be inactivated by the phospholipids of the egg yolk (5). Verbist and Gyselen (8) isolated one rifampinresistant colony of M. tuberculosis per 1,000 to 10,000 viable organisms inoculated onto LJ medium containing 2.5 Mg of rifampin per ml prior to inspissation. Using the inocula of 50 to 500 viable units, we isolated no resistant mutants from 15 strains of M. tuberculosis which had been inoculated onto 7H-10 medium containing 0. The relatively low MIC of rifampin for M. kansasii and scrofula scotochromogens (Fig. 2) suggests this drug for the treatment of these mycobacterioses in man. M. kansasii strains studied by Hobby were sensitive to 0.02 to 10.0 Mug of rifampin per ml in liquid media (4) . Careful susceptibility testing of M. kansasii and scrofula scotochromogens revealed some of these strains to be as sensitive to rifampin as was M. tuberculosis, although others were only inhibited by 2 ,g/ml or more. More than 5 ,g of rifampin per ml was required for the inhibition of M. intracellulare and M. fortuitum. However, 14 out of 16 strains of M. intracellulare were inhibited by 1 Mg of rifampin combined with 5 Mug of INH per ml of 7H-10 medium. Two of the 14 strains were tested against INH-rifampin combinations under simulated in vivo conditions and both strains eventually survived the daily 10-hr drug treatment by virtue of selection of INH-rifampinresistant mutants. For the elimination of multiple drug-resistant populations of M. intracellulare, a two-drug combination of INH-rifampin does not seem to be sufficient; and the addition of neither cycloserine, ethionamide, nor erythromycin to the 2-drug regimen enhanced the antimicrobial effect.
These in vitro studies demonstrate that rifampin has an antituberculous activity comparable to that of INH and streptomycin. Further, these
